Iradimed Corp (IRMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Sales | 17,929 | 17,598 | 17,452 | 16,505 | 16,130 |
| Cost of Goods | 3,919 | 4,210 | 4,039 | 3,667 | 3,944 |
| Gross Profit | 14,010 | 13,388 | 13,413 | 12,837 | 12,187 |
| Operating Expenses | 9,302 | 8,850 | 8,292 | 7,599 | 8,167 |
| Operating Income | 5,627 | 4,748 | 5,160 | 5,905 | 4,963 |
| Other Income | 642 | 495 | 522 | 503 | 335 |
| Pre-tax Income | 6,269 | 5,244 | 5,682 | 6,409 | 5,298 |
| Income Tax | 1,368 | 1,107 | 1,142 | 1,341 | 1,119 |
| Net Income Continuous | 4,901 | 4,137 | 4,540 | 5,067 | 4,180 |
| Net Income | $4,901 | $4,137 | $4,540 | $5,067 | $4,180 |
| EPS Basic Total Ops | 0.39 | 0.33 | 0.36 | 0.40 | 0.33 |
| EPS Basic Continuous Ops | 0.39 | 0.33 | 0.36 | 0.40 | 0.33 |
| EPS Diluted Total Ops | 0.38 | 0.32 | 0.35 | 0.40 | 0.33 |
| EPS Diluted Continuous Ops | 0.38 | 0.32 | 0.36 | 0.40 | 0.33 |
| EPS Diluted Before Non-Recurring Items | 0.38 | 0.32 | 0.36 | N/A | N/A |
| EBITDA(a) | $5,826 | $4,974 | $5,365 | $6,095 | $5,150 |